SCHEDULE 13G/A 0002050902 XXXXXXXX LIVE 1 Common Stock, $0.001 par value per share 10/16/2025 0001454789 Astria Therapeutics, Inc. 04635X102 22 Boston Wharf Road 10th Floor Boston MA 02110 Rule 13d-1(c) ForGrowth III PA B.V. b P7 0 0 0 0 0 N 0.0 OO Forbion Growth Opportunities Fund III Cooperatief U.A. b P7 0 0 0 0 0 N 0.0 OO Forbion Growth III Management B.V. b P7 0 0 0 0 0 N 0.0 OO Astria Therapeutics, Inc. 22 Boston Wharf Road, 10th Floor, Boston, MA 02110 This statement is being filed by ForGrowth III PA B.V. ("ForGrowth III"), Forbion Growth Opportunities Fund III Cooperatief U.A. ("Forbion Growth III COOP") and Forbion Growth III Management B.V. ("Forbion Growth III"). ForGrowth III, Forbion Growth III COOP and Forbion Growth III are sometimes referred to collectively as the "Reporting Persons". The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands. Each of the Reporting Persons is organized under the laws of the Netherlands. Y As of the date of this filing, none of the Reporting Persons may be deemed to beneficially own any shares of Common Stock of the Issuer. 0.0% 0 0 0 0 N Y Y Y N The Reporting Persons are making this single, joint filing because they may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a "group" for purposes of Rule 13d-5 or for any other purpose. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. ForGrowth III PA B.V. /s/ M.A. van Osch and /s/ G.J. Mulder 11/14/2025 Forbion Growth Opportunities Fund III Cooperatief U.A. /s/ M.A. van Osch and /s/ G.J. Mulder 11/14/2025 Forbion Growth III Management B.V. /s/ M.A. van Osch and /s/ G.J. Mulder 11/14/2025